Literature DB >> 8075877

Cell inward transport of L-DOPA and 3-O-methyl-L-DOPA in rat renal tubules.

P Soares-da-Silva1, M H Fernandes, P C Pinto-do-O.   

Abstract

1. The present study has determined the kinetics of the uptake of L-3,4-dihydroxyphenylalanine (L-DOPA) and 3-O-methyl-L-DOPA (3-OMDOPA) in rat renal tubules and examined the effect of 3-OMDOPA on the inward transport of L-DOPA and on its conversion into dopamine in kidney homogenates. 2. The accumulation of both L-DOPA and 3-OMDOPA in renal tubules was found to occur through non-saturable and saturable mechanisms. The kinetics of the saturable component of L-DOPA and 3-OMDOPA uptake in renal tubules were as follows: L-DOPA, Vmax = 11.1 nmol mg-1 protein h-1 and Km = 216 microM (n = 6); 3-OMDOPA, Vmax = 8.1 nmol mg-1 protein h-1 and Km = 231 microM (n = 5). The diffusion constant of the non-saturable component for the accumulation of L-DOPA and 3-OMDOPA was 0.0010 and 0.0014 mumol-1, respectively. 3. 3-OMDOPA (100 to 2000 microM) was found to produce a concentration-dependent decrease (29% to 81% reduction) of the saturable component of the tubular uptake of L-DOPA; the Ki value of 3-OMDOPA for inhibition of L-DOPA uptake was found to be 181 microM (n = 5). The accumulation of L-DOPA obtained in experiments conducted at 4 degrees C was not affected by 3-OMDOPA. 4. In experiments conducted in kidney homogenates only L-DOPA (10 to 5000 microM) was found to be decarboxylated. The Vmax and Km values for aromatic L-amino acid decarboxylase determined in the absence of 3-OMDOPA (Vmax = 14.1 nmol mg-1 protein h-1; Km =62 MicroM) were not significantly different from those observed when the decarboxylation of L-DOPA was carried out in the presence of 1000 MicroM 3-OMDOPA (Vmax = 15.7 nmol mg-1 protein h-1; Km = 68 MicroM).5. It is concluded that the tubular uptake of both L-DOPA and 3-OMDOPA occur through nonsaturable and saturable mechanisms; only the saturable tubular uptake of L-DOPA was found to be inhibited by 3-OMDOPA. It is further shown that 3-OMDOPA neither undergoes decarboxylation into 3-MT nor affects the decarboxylation of L-DOPA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8075877      PMCID: PMC1910353          DOI: 10.1111/j.1476-5381.1994.tb13118.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Importance of O-methylation in dopamine-induced motor and behavioral phenomena.

Authors:  M D Furgeson; R E Dill; R L Dorris
Journal:  Brain Res       Date:  1976-03-19       Impact factor: 3.252

2.  3-O-methyldopa uptake and inhibition of L-dopa at the blood-brain barrier.

Authors:  L A Wade; R Katzman
Journal:  Life Sci       Date:  1975-07-01       Impact factor: 5.037

3.  IN-VITRO DECARBOXYLATION OF NEW PHENYLALANINE DERIVATIVES.

Authors:  R FERRINI; A GLAESSER
Journal:  Biochem Pharmacol       Date:  1964-05       Impact factor: 5.858

Review 4.  New selective COMT inhibitors: useful adjuncts for Parkinson's disease?

Authors:  P T Männistö; S Kaakkola
Journal:  Trends Pharmacol Sci       Date:  1989-02       Impact factor: 14.819

5.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

6.  Effect of chronic administration of L-dopa on catechol-O-methyltransferase in rat tissues.

Authors:  N S Sharpless; G M Tyce; C A Owen
Journal:  Life Sci I       Date:  1973-02-01

7.  Cellular mechanisms of renal tubular transport of I-dopa and its derivatives in the rat: microperfusion studies.

Authors:  Y L Chan
Journal:  J Pharmacol Exp Ther       Date:  1976-10       Impact factor: 4.030

8.  The clinical picture and plasma levodopa metabolite profile of parkinsonian nonresponders. Treatment with levodopa and decarboxylase inhibitor.

Authors:  L Rivera-Calimlim; D Tandon; F Anderson; R Joynt
Journal:  Arch Neurol       Date:  1977-04

9.  Catechol-O-methyltransferase activity: a determinant of levodopa response.

Authors:  D K Reilly; L Rivera-Calimlim; D Van Dyke
Journal:  Clin Pharmacol Ther       Date:  1980-08       Impact factor: 6.875

10.  Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.

Authors:  M Da Prada; R Kettler; G Zürcher; R Schaffner; W E Haefely
Journal:  Eur Neurol       Date:  1987       Impact factor: 1.710

View more
  12 in total

1.  Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine.

Authors:  R Pedrosa; P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Antagonistic actions of renal dopamine and 5-hydroxytryptamine: endogenous 5-hydroxytryptamine, 5-HT1A receptors and antinatriuresis during high sodium intake.

Authors:  P Soares-da-Silva; M A Vieira-Coelho; M Pestana
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

3.  Antagonistic actions of renal dopamine and 5-hydroxytryptamine: increase in Na+, K(+)-ATPase activity in renal proximal tubules via activation of 5-HT1A receptors.

Authors:  P Soares-da-Silva; P C Pinto-do-O; A M Bertorello
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

4.  Studies on the pharmacology of the inward transport of L-DOPA in rat renal tubules.

Authors:  P C Pinto-do-O; P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

5.  Modulation of gastrin processing by vesicular monoamine transporter type 1 (VMAT1) in rat gastrin cells.

Authors:  I Hussain; G W Bate; J Henry; P Djali; R Dimaline; G J Dockray; A Varro
Journal:  J Physiol       Date:  1999-06-01       Impact factor: 5.182

6.  Acute regulation of renal Na+/H+ exchanger NHE3 by dopamine: role of protein phosphatase 2A.

Authors:  I Alexandru Bobulescu; Henry Quiñones; Serge M Gisler; Francesca Di Sole; Ming-Chang Hu; Mingjun Shi; Jianning Zhang; Daniel G Fuster; Nancy Wright; Marc Mumby; Orson W Moe
Journal:  Am J Physiol Renal Physiol       Date:  2010-02-24

7.  Genomic regulation of intestinal amino acid transporters by aldosterone.

Authors:  João S Amaral; Maria João Pinho; Patrício Soares-da-Silva
Journal:  Mol Cell Biochem       Date:  2008-03-18       Impact factor: 3.396

8.  Ontogenic aspects of liver and kidney catechol-O-methyltransferase sensitivity to tolcapone.

Authors:  M A Vieira-Coelho; P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

9.  Characterization of the interaction between muscarinic M2 receptors and beta-adrenoceptor subtypes in guinea-pig isolated ileum.

Authors:  H Reddy; N Watson; A P Ford; R M Eglen
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

10.  Dopamine D3 receptor-mediated inhibition of Na+/H+ exchanger activity in normotensive and spontaneously hypertensive rat proximal tubular epithelial cells.

Authors:  Rui Pedrosa; Pedro Gomes; Chunyu Zeng; Ulrich Hopfer; Pedro A Jose; Patrício Soares-da-Silva
Journal:  Br J Pharmacol       Date:  2004-07-20       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.